Normative and Student Comparisons Did Not Supply a Matched Cannabis-Treatment Baseline

Medical cannabis patients matching or outperforming a normative sample and student comparison group does not, by itself, show what those patients would have done without acute treatment. The comparator defines the inference.

The reviewed study used external benchmarks

Eadie and colleagues describe medical cannabis patients assessed with a Brief Neurocognitive Battery and compared with the battery’s normative data and forty non-cannabis-using undergraduate students. The review reports favorable comparisons at the observed post-intake assessments.

A benchmark comparison is not an individualized treatment contrast

External norms describe a reference population. A student comparison describes another selected group. Neither automatically controls for every difference in age, education, health, baseline skill or exposure history. Matching a benchmark does not establish that a participant experienced no change from their own untreated performance.

The result remains useful within its scope

The observations can describe performance relative to the chosen comparators. They cannot independently prove that cannabis enhanced cognition, establish equivalence for all functions or validate a personal driving clearance. This distinction does not assume that the patients were impaired; it identifies what the design can answer. A scientific opinion should state whether the question concerns absolute performance against a norm or a causal effect of treatment, and use a comparison appropriate to that question.

Related analysis: the review’s broader findings and limitations.

Research cited

This analysis draws on the supplied review: Eadie and colleagues (2021). Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review. Frontiers in Psychiatry.